Recent developments in gene editing technology have enabled scientists to modify DNA sequence by using engineered endonucleases. These gene 
Introduction
Sickle cell disease (SCD) is a devastating disease with significant morbidity and mortality rate (Gardner, 2018) . The disease is characterized as a monogenic blood disease caused by a point mutation in the human β -globin gene (HBB) encoding the subunits of hemoglobin. SCD occurs due to mutated HBB allele called hemoglobin S (HbS). The point mutation (substation of A to T) in the sixth codon of HBB gene leads to the conversion of valine amino acid to glutamic acid, resulting in significant changes in the behavior and conformation of the hemoglobin molecule (Frenette and Atweh, 2007; Gardner, 2018) . Abnormal HbS hemoglobin results in the collection and polymerization of the protein, which forms red blood cells in the form of sickle.
Unlike doughnut shaped, elastic normal red blood cells; sickle cells have a stiff and sharp sticky structure that easily aggregate and stick on interior surface of the narrow blood vessels. As a result of occlusion, tissues are inadequately oxygenated and organ damage is seen after disease progression (Ashley-Koch et al., 2000) . In addition, sickle-shaped red blood cells have a shorter life span than normal red blood cells, which may cause chronic anemia that has further pathological effects on patients health (Azar and Wong, 2017; Gardner, 2018) . Clinically, the presence of homozygous variant (HbSS) is the most severe form of SCD compare to heterozygous mutations (Frenette and Atweh, 2007) .
Sickle cell disease, one of the most common hereditary diseases in the world, is not only of clinical importance, but also an economic and globally vital issue (Gardner, 2018; Kapoor et al., 2018) . It has been reported that around 100,000 patients have been diagnosed with SCD only in USA (Hassell, 2010; Piel, 2013; Wierenga et al., 2001) . Prevalence of HgS trait and β -thalassemia trait (another common form of HBB mutation) raise up to 10% and 13.1% in some regions of Turkey, respectively (Altay and Gurgey, 1986; Beksac et al., 2011; Bircan et al., 1993; Canatan, 2014; Canatan et al., 2006; Guvenc et al., 2012; Kilinc, 2006; Mendilcioglu et al., 2011; Topal et al., 2015; Tosun et al., 2006; Zeren et al., 2007) . The disease has a high prevalence especially in sub-Saharan Africa, Mediterranean basin, Middle East and India. SCD is an increasing global health problem. Estimates suggest that approximately 6 300,000 infants are born with sickle cell anemia each year, and this number may increase up to 400,000 by 2050 (Piel et al., 2017) . Despite of high incidence of SCD, still there is not any definitive treatment for it. Current treatments are predominantly available as supportive agents to reduce disease severity and background complications. The most commonly used clinical applications in SCD patients are blood transfusion, hydroxyurea therapy and vaccinations to prevent the risk of serious infections (Aliyu et al., 2006 ).
Allogeneic stem cell transplantation, a promising treatment for SCD and similar blood diseases, is based on the availability of suitable donors, harvesting of healthy HSCs and their transplantation to the patients (Kahraman et al., 2014; Ozdogu et al., 2018b; Shenoy, 2011; Yesilipek, 2007; Yesilipek et al., 2018) . Even though there are successful results of this method, it is not a universal treatment because of insufficiency of available donors, the immune issues like graft versus host disease (GVHD) and other toxicities (Ozdogu et al., 2018a; Ozdogu et al., 2018b) . Autologous transplantation of ex vivo corrected HSCs have been proposed as a promising method to eliminate the drawbacks of allogeneic transplantation (Simsek et al., 2010; Yucel and Kocabas, 2018) . Monogenic blood diseases, such as SCD, can be treated by correcting mutations directly using genome editing tools, also called engineering nucleases. These nucleases have been shown to have high potential for therapeutic applications in previous studies (Kuscu et al., 2014) . Recently, type II CRISPR / Cas9 system become the most fashionable tool for genome editing and a promising approach for the direct correction of mutations that cause monogenic diseases such as SCD (Hoban et al., 2016b; Vakulskas et al., 2018) .
The CRISPR/Cas9 nuclease system is composed of the DNA-binding CRISPR RNA (crRNA) array that encodes for the guide-RNA (gRNA), the auxiliary trans-activating crRNA, and the Cas9 nuclease (Hussain et al., 2019) . The CrRNA contains 20-nucleotides (nt) guide sequence that binds to specific 20 base pairs DNA target in the genome by Watson-Crick base pairing. Target recognition by Cas9 nuclease depends on the protospacer contiguous motif (PAM) sequence associated with the DNA binding region.
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The Cas9 nuclease induces double-stranded break three base pairs upstream of the PAM sequence. Although the CRISPR / Cas9 system is the most recently developed genome editing tool, it has recently been a striking tool for site-specific genome editing as well.
Sickle cell disease is one of the inherited diseases that is hoped to lead a cure by gene editing technology. Since it is caused by a point mutation on HBB gene, it is possible to efficiently induce base change to restore functional beta subunit of the hemoglobin. Recent studies have showed the applicability of HBB repair through application of CRISPR/Cas9 system in CD34+ HSCs (DeWitt et al., 2016 
Materials and Methods

Cell Lines and Culture Conditions
Human embryonic kidney cell line (HEK293T) was purchased from ATCC (American Type Cell Collection). HEK293T cells were cultured in high glucose (4.5 g/L) Dulbecco's Modified Eagle Medium supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin-Streptomycin (Aksoz et al., 2018; Kocabas et al., 2015b) . Cells were maintained at 37°C, 5% CO 2.
Design of gRNAs
Exact genomic location of the most common mutation (rs334) causing SCD was determined using online SNP database of National Center for Biotechnology Information (NCBI). Reference genomic sequence of HBB gene and neighboring sequences were obtained from NCBI gene database.
Using SnapGene desktop tool, exact site of rs334 was located and 100 bp length target sequence centering the possible mutation site was picked.
Guide RNA sequences were determined using online gRNA design tool (available at http://crispr.mit.edu/) by Zhang Lab, MIT. 13 candidate gRNA sequences were suggested by the tool, listing the on-target scores and possible off-target numbers for each gRNA. The gRNA sequence which has the highest score and closest distance to the rs334 was picked. Moreover, 7
bp longer version of this gRNA sequence was designed. The gRNA sequence obtained as 20 bp length was elongated from its 5' direction, resulting in 27 bp long gRNA ( Table 1) . (Kocabas and Aslan, 2015; Kocabas et al., 2012a; Kocabas et al., 2015a; Kocabas et al., 2015b; Mahmoud et al., 2013; Rimmele et al., 2015; Simsek et al., 2010) . Reaction mix was placed in thermocycler for 30 minutes at 37°C for incubation.
Following incubation, FastAP Thermosensitive Alkaline Phosphatase was added into the digestion mix as 4 µl of Alkaline Phosphatase, 3 µl of 10X
FastAP Buffer, and 3 µl of nuclease free water. Tube was placed back into the thermocycler and set to 37°C for 20 minutes followed by 80°C for 15 minutes. This is followed by DNA gel purification. 1%(w/v) agarose gel was prepared in TBE buffer. Digested and dephosphorylated plasmid mix was loaded into the well. Electroporation was conducted for 40 minutes at 150 V. After 40 minutes, agarose gel was visualized under UV transilluminator. Band around 9.2 kb was dissected using a scalpel and placed into eppendorf tube, and the weight was measured. NucleoSpin® Gel and PCR Clean-up Kit was used for plasmid purification from the gel. To solubilize the gel slice, 200 µl of NTI buffer was added for each 100 mg of agarose gel. Sample was incubated for 5-10 minutes at 50°C until the gel was dissolved, and vortexed briefly.
Column was placed into a collection tube and up to 700 µl of sample was loaded. Sample was centrifugated at 11,000 x g for 30 seconds. Flow-through was discarded. To wash the silica membrane, 700 µl of NT3 Buffer was 1 1 added into the column and centrifugated for 30 seconds at 11,000 x g. Flowthrough was discarded. Column was centrifugated at 11,000 x g for 1 minute
to dry the membrane. Column was placed into a clean eppendorf tube and 30 µl of prewarmed NE buffer was added directly over the membrane. Sample was incubated at room temperature for 1 minute, then centrifugated for additional 1 minute at 11,000 x g. Concentration was measured using NanoDrop.
Ligation of the pSpCas9(BB)-2A-GFP Plasmid Backbone and gRNA Insert
Ligation reaction was set as 50 ng of purified pSpCas9(BB)-2A-GFP plasmid backbone, 1 µl of annealed gRNA Oligos (1:200), 1 µl of T4 DNA Ligase, 2 µl of 10X T4 DNA Ligase Buffer, and completed up to 2u µl with nuclease free water as we have done previously (Kocabas and Aslan, 2015; Kocabas et al., 2012a; Kocabas et al., 2015a; Kocabas et al., 2015b; Mahmoud et al., 2013; Rimmele et al., 2015; Simsek et al., 2010) . Reaction mix was incubated in thermocycler at 22°C for 90 minutes. Tubes were left overnight at RT. Mix was used for bacterial transformation by heat shock procedure.
Bacterial Transformation by Heat Shock
Chemically competent DH5α cells (50 µl) were thaw on ice. Ligated plasmids were placed on ice for 10 minutes. 7 µl of ligation mix was added into bacteria by pipetting gently. Bacteria mixture was incubated on ice for 25 minutes.
Tubes were placed on heat block adjusted to 42°C for 45 seconds and immediately placed on ice again for 3 minutes to provide heat shock. 250 µl of SOC medium was added to each tube. Cells were incubated in shaking incubator at 37°C, 150 rpm for 120 minutes. Inoculum was spread over Ampicillin (+) agar plates. Plates were incubated overnight in 37°C incubator.
Colonies were observed the next day. This is followed by colony selection and miniprep isolation from individual colonies as we have done previously (Kocabas and Aslan, 2015; Kocabas et al., 2012a; Kocabas et al., 2015a;  1 2 Kocabas et al., 2015b; Mahmoud et al., 2013; Rimmele et al., 2015; Simsek et al., 2010 ).
Verification of gRNA insert by Polymerase Chain Reaction (PCR)
The primers listed in the Table 2 Plasmids isolated by midiprep protocol were sent to Medsantek, Turkey for sequencing. Directional Sanger sequencing was performed using 10 µM primer Cloning Forward given in Table 2 was used. The plasmid DNA concentrations were adjusted to 100 ng/µl.
Mammalian cell transfections
Polyethylenimine (PEI) was used for mammalian cell transfections as we have done previously (Boztas et al., 2013; Kocabas and Aslan, 2015; Kocabas et al., 2015a; Rimmele et al., 2015) . Briefly, HEK293T cells were seeded in 6 well plate with 3x10 5 density and cultured in 2 ml DMEM high glucose supplemented by 10% FBS, no antibiotics. Cells were incubated overnight at 37 o C, 5% CO 2 and 95% RH. In a 1.5 ml tube, 1 µg pSpCas9(BB)-2A-GFP-gRNA was diluted in 200 µl serum-free DMEM. Control mix was prepared with pSpCas9(BB)-2A-GFP without gRNA. 2 µg PEI (1 mg/ml stock) was added and mixed well (DNA: PEI ratio is 1:2). The mixture was incubated at room temperature for 15 minutes. The mixture was added to the culture media dropwise and mixed without disturbing the cells. Cells were placed in the incubator and incubated for 16-24 hours. GFP expression was checked under fluorescent microscope. GFP expression and confluency was analyzed.
Cells were harvested by trypsinization for downstream applications.
Transfection efficiency was analyzed by fluorescence microscopy and flow cytometer based on the analysis of GFP. To this end, 24 hours after transfection, cells were examined under inverted fluorescence microscope (Zeiss Axio Vert.A1) as we have done previously (Mahmoud et al., 2013) .
Filter was set to FITC mode and imaging was performed with 5X and 10X
magnifications. Images were recorded in TIFF format. Flow cytometer were used to determine GFP expressing cell population using Beckman Coulter's CytoFLEX S flow cytometry device as we have done previously (Aksoz et al., 2018; Kocabas et al., 2015b; Kocabas et al., 2012b; Simsek et al., 2010; Zheng et al., 2014) . HEK293T cells were harvested by trypsin and washed twice with PBS. Cell suspensions were transferred into 96 well plates and the plates were placed to the plate reader part of the device. Acquisition was set Results were recorded as histogram and dot plot.
Detection of indels by standard and long gRNAs
Genomic DNA was isolated from cell transfected with pSpCas9 ( seconds. Lysate was transferred into spin column. The column was centrifuged at 10.000 x g for 1 minute. Collection tube was discarded, and column was placed into a new collection tube. 500 µl of Wash Buffer 1 was added to the column and centrifuged at 10.000 x g for 1 minute. Collection tube was replaced and 500 µl of Wash Buffer 2 was added to the column.
Column was centrifuged at maximum speed for 3 minutes. Collection tube was discarded, and column was placed in a 1.5 Eppendorf tube. 50 µl of Genomic Elution Buffer was added to the column and incubated at RT for 1 minute. Tube with column was centrifuged at max speed for 1 minute. Elution step was repeated for maximum recovery of DNA. Column was discarded and DNA within the tube was measured with NanoDrop. This is followed by PCR amplification of target locus.
The primers listed in the (Mahmoud et al., 2013) to determine % of indels. To this end, digested band densities and non-digested band intensities quantified. Digested band density divided by total band density to determine the percentage of indel formation.
PCR Amplification and TA cloning of wild type genomic DNA HDR
The primers listed in the HBB-1kb-F TCTGGAGACGCAGGAAGAGA HBB-1kb-R ACGATCCTGAGACTTCCACAC HBB-2kb-F CCTACCCCTACTTTCTAAGTCA HBB-2kb-R GATACATTGTATCATTATTGCCCT
Site Directed Mutagenesis in HDR template
Primers for site directed mutagenesis were designed using online In-Fusion
Cloning Primer Design Tool (available https://www.takarabio.com/learningcenters/cloning/in-fusion-cloning-tools). The primers listed in the Takara, 638910). This is followed by in-fusion reaction for site directed mutagenesis as we have done previously (Kocabas and Aslan, 2015; Kocabas et al., 2015a) . Reaction was incubated at 50°C for 15 minutes.
Plasmids were digested using HindIII restriction enzyme for verification of site directed mutagenesis and run 1% agarose gel. ImageJ was used to determine (Mahmoud et al., 2013 ) percent of HDR event by analyzing corresponding band densities, and by normalizing the transfection efficiency as determined by flow cytometric analysis of GFP+ cells. Table 6 with PEI method. 12 hours after transfection, culture media was changed with 
Results
Verification of gRNA inserts into pSpCas9(BB)-2A-GFP vector
To confirm the successful cloning of gRNA sequences into pSpCas9(BB)-2A-GFP plasmids, PCR amplification for the cloning site was performed. In PCR reaction, the primer named Cloning-F was used as the standard forward primer annealing the U6 promoter located upstream of the gRNA cloning site ( Figure 1A) . The reverse strands of oligo DNAs previously designed and used for gRNA insert production were used as the reverse primer for each gRNA inserted plasmid. It was expected to obtain a 100 bp PCR product if the gRNA sequence is successfully cloned in to plasmid. In the absence of gRNA insertion, reverse primer would not anneal to template plasmid DNA therefore there would not be any visualized PCR product in agarose gel.
Cloning results were also verified with Sanger sequencing method. PCR 
Detection of Indel formation at HBB locus
Equal number of cultured HEK293T cells were transfected with the same amount of pSpCas9(BB)-2A-GFP plasmids using PEI transfection reagents to 2 1 figure out the most efficient way to deliver Cas9 endonuclease, gRNA and/or HDR templates. 24 hours post-transfection, cells were examined under fluorescent microscope ( Figure S1 ). Each well containing 300,000 cells were transfected with 1 µg of plasmid. In PEI transfections, to obtain 1:2 and 1:3 DNA:PEI ratios, 2 µg and 3 µg of PEI were used respectively ( Figure S1A ).
PEI has shown optimal transfection efficiency and GFP expression at these ratios. The increased amount of PEI resulted in an increase in cell death.
Thus, we have used 1:2 DNA to PEI ratio in transfection studies in HEK293T T7 Endonuclease (T7E) based assay was used to evaluate the activity of both gRNA on target locus. Briefly, genomic DNAs were isolated from HEK293T cells transfected with HBB gRNA and HBB long-gRNA Cas9-GFP. Primers for the gDNA PCR were designed to produce 1 kb product, centering the DNA sequence targeted by gRNAs. It was expected to generate 500 bp band on agarose gel after T7E treatment to PCR products if the gRNA successfully induce DSBs resulting in indel mutations. PCR products derived from gene targeted cells were proceeded to mismatch cleavage assay, followed by agarose gel electrophoresis (Figure 2A) . The data indicates that both HBB gRNA and HBB long-gRNA pSpCas9(BB)-2A-GFP vectors successfully functioned and showed similar cleavage activity (up to 40 % indels in whole cells) on target DNA sequence ( Figure 2B ). Cells transfected with Cas9 only did not show any DSB on target locus since there was not a gRNA for gene targeting. In addition, when we normalized the % indels per GFP+ cells (see Figure S1C ), we have found that studied gRNAs are able to cause indel formation up to 88% in transfected cells ( Figure 2C) . Intriguingly, longer gRNA has showed slightly better performance of targeting and cleavage on target locus, in comparison to standard length gRNA. In theory, longer gRNA would have less off-target effects on genome. Since long gRNA has the same 2 2 or better targeting efficiency and functionality on target site, it could be preferred to use for future application rather than using standard length gRNA. Thus, it would be possible to reduce off-target mutations without losing on-target activity. Indeed, off-target predictions demonsrated a significant reduction in the off-targets by long gRNA targeting SCD mutation. HBB standard gRNA and long gRNA were subjected to off-target prediction with
Cas-OFFinder tool. Numbers of off-target were compared for every given parameter. DNA bulge, RNA bulge 0,1 and 2 were characterized along with upto 9 mismatches to determine potential targets. We have determined up to 99% reduction by HBB long gRNA compared to standard gRNA off-targets predicted (Supplementary File 1) .
Generation of HDR templates
Wild type genomic DNA from HEK293T cells was isolated and target locus encompassing HBB gene was amplified by PCR to perform TA cloning ( Figure 3A) . Taq polymerase was used to obtain PCR products with TA overhangs. Primer pairs were designed to produce 1kb, and 2kb DNA fragments centering the gRNA binding site. PCR reactions were prepared, and product sizes were examined by agarose gel electrophoresis ( Figure   3B ). The result indicates that 1 Kb and 2 Kb fragments were successfully produced in correct size and without any unspecific products. PCR products with 1 Kb and 2 Kb size were gel purified and were directly used for TA cloning protocol. DNA fragments were ligated to linearized pCR 2.1 plasmid and bacterial transformation was performed. The cloning site of this plasmid is in LacZ alpha sequence, allowed us to perform the blue-white screening of transformed colonies. White colonies were selected and plasmids were isolated. To ensure the insert size in the selected plasmids, EcoRI digestion was performed. Digestion with EcoRI confirmed the correct insertions into pCR 2.1 plasmids ( Figure 3C , colony 2 for 1 Kb HDR amplicon and colony 1 for 2 Kb HDR amplicon). Plasmids with about 4.9 Kb and 5.9 Kb total size were selected for the site directed mutagenesis step to replace PAM sequence with HindIII restriction site.
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We aimed to achieve targeted gene editing of SCD mutation to WT sequence via HDR mechanism. In addition, PAM sequence on the wild type sequence aimed to be replaced with HindIII restriction enzyme recognition sequence ( Figure 3A) . To this end, we used in-fusion cloning system to mutagenize and generate HBB-HDR-1Kb-NoPAM ( Figure 3B ) and HBB-HDR-2Kb-NoPAM (Figure 3C ) plasmids. To confirm the sequence modification on HDR templates, restriction digestion with HindIII enzyme was performed. Digested products were run 1% (w/v) agarose gel. The agarose gel image indicates that the PAM sequence in 1 Kb or 2 Kb wild type HDR templates was successfully replaced with HindIII recognition site ( Figure 4D and 4E) .
Co-Delivery of Cas9-gRNA and HDR vectors
The final and most crucial step of this study was the delivery of Cas9, gRNA and HDR templates to induce site-specific genetic modification. HBB longgRNA-pSpCas9(BB)-2A-GFP vector was introduced in the form of plasmid.
HDR templates were delivered as circular plasmids carrying 1kb and 2 kb total homology lengths and the added HidIII site for the screening of HDR events in target cells. Transfection was done using 1:2 DNA to PEI protocol which was previously suggested as the most efficient method for this cell line 
Discussion
Several million people in the world are affected with sickle cell disease and there is no definitive cure for it (Demirci et al., 2018 locus of interest. For these purpose, two different gRNAs were designed to target the close proximity of SCD mutation. The first gRNA was a standard gRNA with 20 bp long spacer sequence with 12 bp distance to the SCD point mutation. The second gRNA named HBB long-gRNA was 25 bp in size. Long gRNA was designed by addition of extra 7 bases at the 5' end of first gRNA to increase on-target efficiency. HBB long-gRNA also included SCD specific mutation thus it's designed to have SCD specificity. The effect of gRNA length was investigated with the on-target mutagenesis analysis using T7E assay, and no significant difference was observed in terms of full-length and long gRNA activities on target locus. Indeed, use of full-length or longer gRNA is thought to be better for gene editing strategies when effectiveness is a key concern (Zhang et al., 2016) . It was reported that longer gRNA sequences would decrease the off-target effects due to increased specificity of matching to on-target (Zhang et al., 2016) .
Two different sizes of HDR templates were generated and tested in the present of SCR7 small molecules. SCR7 is small molecule and inhibitor of DNA Ligase IV, which has important role in NHEJ mechanism. Previous studies have reported that 1 µM SCR7 treatment to iPSCs resulted in significant increase in HDR mediated gene editing, inhibiting NHEJ mechanism (Chu et al., 2015) . After co-delivery of gene editing components into HEK293T cells, transfection efficiencies were evaluated using flow cytometry. Transfection efficiencies were in a range between 50-60%. It was observed that increased total amount of plasmids resulted in increased cell death due to higher amounts of PEI used for transfection.
Presence of PAM sequence in the HDR template causes re-cutting by Cas9 nuclease and indel formation even after correction of desired mutation in the target location (Zhang et al., 2014) . Thus, we have developed tools to remove PAM sequence as a proof-of-concept. In-fusion cloning system was utilized to remove PAM sequences in wild type HDR templates through a site directed mutagenesis. The PAM sequence downstream of gRNA binding site was replaced with HindIII recognition sequence to avoid Cas9 cleavage activity on 2 7
HDR templates. Besides, HindIII sequence was used as a marker of gene editing on HEK293T cells. In case of successful gene editing via HDR mechanism, we would expect to observe cleavage on the PCR amplified target locus when treated with HindIII.
Various studies targeted HBB gene with different gene editing methodologies in various types of cell and cell lines (Antony et al., 2018; Cai et al., 2018; Chattong et al., 2017; Dever et al., 2016; Hoban et al., 2016a; Vakulskas et al., 2018; Wattanapanitch et al., 2018; Ye et al., 2016) . However, our study is the first study testing long gRNA including SCD specific mutation and its effects in HBB gene editing. This study provides proof of concept that using long version of gRNAs effective in target disruption or correction in human cells. It is also noteworthy that long-gRNA with SCD mutation would likely to have less off-target activity when used in temporal manner since longer gRNA has higher affinity to and more specificity to on-target locus. In addition, the two HDR donor templates in circular form (1 Kb and 2 Kb) were generated in this study led to similar gene editing efficacy. These templates could be used to cover all possible mutations reported for HBB. 
